Christian Doppler Laboratory for Taste Research
Vienna, 1090, Austria
NCT Number: NCT05705596
The aim of this cross-over intervention study is to investigate the influence of the sweet-modulating substance hesperetin in combination with sucrose in comparison to an equally sweet-tasting sucrose-only solution on markers of energy metabolism.
Looking for future studies?
Notify Me18 year–45 year
Male
Interventional
Early Phase 1
Vienna, 1090, Austria
The study is designed as a randomised cross-over intervention study with two arms. The aim is to investigate the influence of a 10% sucrose solution, corresponding to the sugar content of a conventional soft drink, compared to an equally sweet-tasting 7% sucrose solution in combination with 50 mg/L of the polyphenol hesperetin, on time-dependent blood glucose fluctuations and ad libitum energy intake in metabolically healthy male volunteers.
To investigate the underlying mechanisms, the individual appetite score, metabolic and hormonal responses to the interventions and circulating extracellular vesicles and their miRNA composition will be measured. In addition, the participants' individual thresholds for sweet taste, preference and consumption for sweet-tasting foods such as sugar and sweeteners, and their body composition will be recorded as potential influencing factors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10% sucrose corresponding to a regular soft drink
Other names: table sugar
increases sweetness of 7% sucrose solution to match sweetness of 10% sucrose solution
Other names: (2S)-3',5,7-Trihydroxy-4'-methoxyflavan-4-one, CAS number 520-33-2
Time frame: 15, 30, 60, 90, and 120 minutes after drinking the test solution
Change compared to baseline in blood glucose concentration [mg/dL] in plasma samples after drinking the test solution
Time frame: Difference between before and 120 minutes after drinking of the test solution
Change compared to baseline in the subjective rating of the individual feeling of hunger, fullness, as well as appetite for a snack or for something sweet on a digital visual analog scale in comparison to baseline
Time frame: 120 minutes after drinking of the test solution
Ad libitum food intake from a standardized breakfast
Time frame: 15, 30, 60, 90, and 120 minutes after drinking the test solution
Change compared to baseline in Insulin, Glucagon-like peptide 1, and Gastric inhibitory polypeptide concentrations [mmol/L] in plasma samples after drinking the test solution
Time frame: 15, 30, 60, 90, and 120 minutes after drinking the test solution
Change compared to baseline in Polypeptide Y, grehlin, cholecystokinin, and serotonin concentrations [mmol/L] in plasma samples after drinking the test
Time frame: 15, 30, 60, 90, and 120 minutes after drinking the test solution
Change compared to baseline in circulating extracellular vesicles and their miRNA composition
University of Vienna
Other
Einfluss Des süßmodulierenden Polyphenols Hesperetin in Kombination Mit Saccharose Auf Die Blutglukose-Regulierung Und Energieaufnahme in Abhängigkeit Der Süßwahrnehmung
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06340087
Blood Glucose Fluctuations, Hunger
Vienna, State of Vienna, Austria
View Trial DetailsNCT04011683
Arrhythmias, Cardiac, Arrythmia, Cardiac
Copenhagen, Denmark
View Trial DetailsNCT06790771
Hunger
Fort Worth, Texas, United States
View Trial DetailsNCT06935058
Fatigue, Glucose Metabolism Disorders
Gorzów Wielkopolski, Polska, Poland
View Trial Details